Proteomics Market Size to Reach USD 57.57 Billion By 2027 | Surge in Genetic and Chronic Diseases and Advancements in Technology are Key Factors Driving Growth of Proteomics Industry, says Reports and Data

Key participants include Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck KgaA, PerkinElmer, Inc., Promega Corporation, Waters Corporation, Bruker Corporation, and GE Healthcare.

New York, New York, UNITED STATES

New York, Feb. 02, 2021 (GLOBE NEWSWIRE) -- The global proteomics market is expected to reach a market size of USD 57.57 Billion by 2027 and register a CAGR of 14.5%, during the forecast period, according to a new report by Reports and Data.

Surge in prevalence of genetic diseases, availability of high funding for research, and advancements in technology are among some key factors driving growth of the global proteomic market. Proteomics uses advanced technologies for the identification and qualification of proteins, coupled with the detection of diagnostic markers. It finds extensive application in drug development and personalized medicine.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@

Proteomic system reduces time and resources required for biological testing and chemical synthesis of drugs. It also simplifies the process of drug discovery. Moreover, opportunities associated with mass spectrometry-based proteomics, biomarker identification, and nanoproteomics is another factor projected to drive growth of the market in the coming years. Several research companies are looking to increase applications of nanotechnology to enhance efficiency, precision, and productivity, which will positively affect growth of the market.

Proteomics instruments are expensive, which limits their adoption in small-scale enterprises and academic institutions. The high-cost factor also creates challenges for expansion of the proteomic market in developing economies.

COVID-19 impact:

The COVID-19 pandemic has propelled growth of the proteomics market. Increasing adoption of proteomics technology for detection of COVID-19 infected patients and discovery of new therapies will contribute to revenue of the market. Pharmaceutical companies are adopting advanced technologies for drug discovery and vaccine development, which is impacting the growth of the market positively.

Further key findings in the report

  • Instrument segment revenue is expected to continue to register steady growth due to technological advancements such as 2D electrophoresis protein analyzers, which can accurately analyze thousands of proteins in a single run. Biochip analyzers and electrophoresis analyzer instruments are generally used in research, and continuous research activities and use is expected to drive revenue growth of this segment in the coming years.
  • Chromatography is an indispensable tool in proteomic research as it provides high-resolution, high-speed, and high-sensitivity separation of macromolecules. Moreover, unique feature of chromatography will also enable detection of low-abundance species, which will drive its demand in the coming years.
  • Clinical diagnosis segment revenue is growing rapidly due to wide applications in disease biomarker discovery, personalized medicine, and drug identification. Advancements in technology and growing trend of personalized medicine will also propel growth of the proteomics market.   
  • Asia Pacific market revenue is forecast to grow at a higher rate due to increasing number of pharmaceutical companies and Contract Research Organizations (CRO). Presence of less-stringent regulations in countries in the region will also support growth of the market.
  • Key participants include Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck KgaA, PerkinElmer, Inc., Promega Corporation, Waters Corporation, Bruker Corporation, and GE Healthcare.

Buy Your Copy Now (Customized Report Delivered as per Your Specific Requirement)@

For the purpose of this report, Reports and Data has segmented the global proteomics market on the basis of product, technology, application, and region:

  • Product Outlook (Revenue, USD Billion; 2017-2027)
    • Instruments
    • Reagents
    • Services
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
    • X-Ray Crystallography
    • Chromatography
    • Microarray Instruments
    • Protein Fractionation Systems
    • Surface Plasma Resonance (SPR) Systems
    • Electrophoresis
    • Spectroscopy
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Clinical Diagnosis
    • Drug Discovery
    • Others

Click on the link to read key highlights of the report and look at projected trends for years to come:

  • Regional Outlook (Revenue, USD Billion; 2017-2027)
    • North America
      1. U.S.
      2. Canada
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • MEA
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA
    • Latin America
      1. Brazil
      2. Rest of LATAM

Take a Look at our Related Reports:

Transit Cards Market Size, Share & Analysis, By Type (Bus Card, Subway Card, Others) By Application (Traffic, Transportation, Others), And By Region, Forecast To 2027

Augmented Reality in Retail Market Information By Device Type (Head Mounted Display, Handheld Device, Smart Augmented Reality Mirror), By Technology (Marker-based Augmented Reality, Marker-less Augmented Reality), By Retail Product Type (Furniture, Clothing, Groceries, Shoes, Jewelry, Toys, Makeup), And Region Forecast To 2027

E-Learning Market Size, Share & Analysis, By Technology (Online Learning, Learning Management Systems, Mobile Learning, Microlearning, Virtual Classrooms), By Application (Academic, Corporate, Healthcare, Government, Others), By Region, Forecast To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports And Data | Web:

Direct Line: +1-212-710-1370


LinkedIn | Twitter | Blogs

Read Full Press Release@